Sequent Scientific (VIYASH) Share Price Rises 5.74% to Rs 227.40 Today
- October 28, 2026
- Posted by: Kunal Singla
- Category: News
Sequent Scientific Share Price rose 5.74% on 28 October 2026. The stock was trading at Rs 227.40 as of 12:07:37 PM IST, against a previous close of Rs 215.05, a gain of Rs 12.35 per share. At this level the market capitalisation of Sequent Scientific stands at Rs 9,166.59 crore, according to latest Univest data.
Sequent Scientific operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. Univest data confirms the move itself, though no company-specific trigger has been identified. That leaves the numbers to tell the story: where the stock sits inside today’s range, how its valuation compares with the industry, and what the reported ratios say about the business behind the share price rise.
Sequent Scientific Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 227.4 |
| Previous Close | Rs 215.05 |
| Today's Move | Rs 12.35 (+5.74%) |
| Open | Rs 212.95 |
| High | Rs 227.4 |
| Low | Rs 212.65 |
| Market Capitalisation | Rs 9,166.59 crore |
| Market Cap Category | Mid Cap |
Sequent Scientific Ltd. (VIYASH) rose to Rs 227.4 from the previous close of Rs 215.05, a move of Rs 12.35 or 5.74%. The stock opened at Rs 212.95, reached a high of Rs 227.4, recorded a low of Rs 212.65.
Sequent Scientific Share Price Today stands at Rs 227.40, up Rs 12.35 or 5.74% from the previous close of Rs 215.05. The stock opened at Rs 212.95, touched a low of Rs 212.65 and a high of Rs 227.40. The open was Rs 2.10 below the previous close, the day low of Rs 212.65 was Rs 0.30 below the open, and the last traded price is level with the day’s high of Rs 227.40.
The price table under this heading lists each level. The day’s range from Rs 212.65 to Rs 227.40 is Rs 14.75 wide, and the current price sits at the very top of it. The stock has added Rs 14.45 since the open of Rs 212.95, and it now trades above the previous close of Rs 215.05 after opening below it.
Because the trading session was still open when this Sequent Scientific Share Price Update was written, these levels can change as trading continues. The 5.74% move is the verified fact of the day. This article does not guess at a reason for it. What the price data establishes is the size of the move and its position inside the range.
A rising price tells only part of the story, so the next step is to look at the ratios that describe the business itself. The fundamentals below show how the valuation and returns behind the Sequent Scientific stock price rise compare with the industry.
Sequent Scientific Ltd. (VIYASH) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 9,166.59 crore |
| P/E Ratio | 55.5x |
| P/B Ratio | 3.38x |
| ROE | 9.06% |
| ROCE | 13.1% |
| EPS | Rs 3.87 |
| Book Value Per Share | Rs 63.66 |
| Dividend Yield | 0% |
Sequent Scientific Ltd. (VIYASH) fundamental metrics show P/E 55.5x, P/B 3.38x, ROE 9.06%, ROCE 13.1%. Read together, these ratios describe the company’s position rather than a recommendation.
Sequent Scientific Ltd. has a market capitalisation of Rs 9,166.59 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.5x, P/B at 3.38x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.06% and ROCE of 13.1%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.87, book value per share of Rs 63.66, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.74x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 55.5x |
| Benchmark Median P/E | 30.74x |
| Benchmark Average P/E | 43.3x |
| Benchmark P/E Range | 3.21x to 577.05x |
| Company P/B Ratio | 3.38x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 9.06% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 13.1% |
| Benchmark Median ROCE | 13.17% |
| Company Market Capitalisation | Rs 9,166.59 crore |
| Benchmark Median Market Cap | Rs 696.43 crore |
Sequent Scientific Ltd. (VIYASH) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Sequent Scientific Ltd. (VIYASH) has a P/E ratio of 55.5x, which is above the benchmark median of 30.74x, a difference of +80.55%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Sequent Scientific Ltd. (VIYASH) has a ROE of 9.06%, which is below the benchmark median of 11.23%, a difference of -19.32%. Sequent Scientific Ltd. (VIYASH) has a ROCE of 13.1%, which is below the benchmark median of 13.17%, a difference of -0.53%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,18,204.09 | 34.91 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,40,780 | 86.02 | 14.25 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,73,828.11 | 82.48 | 9.53 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,520.92 | 25.79 | 4.32 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,11,304.32 | 105.74 | 20.5 | 18.31 | 18.2 |
Sequent Scientific Ltd. (VIYASH) has a P/E ratio of 55.5x compared with the displayed peer median of 82.48x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 9.06% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 13.1% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sequent Scientific Ltd. (VIYASH) has a market capitalisation of Rs 9,166.59 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Sequent Scientific
- Price action: the stock rose 5.74% to Rs 227.40 from a previous close of Rs 215.05 and is level with its day high.
- Valuation: a P/E of 55.50 compares with an industry median of 30.74, while the P/B of 3.38 compares with a median of 2.71.
- Returns: ROE of 9.06% and ROCE of 13.10% compare with the industry medians of 11.23% and 13.17%.
- Per-share data: EPS of Rs 3.87, book value of Rs 63.66 and a dividend yield of 0.00% give the base for the valuation multiples.
- Sector position: market capitalisation of Rs 9,166.59 crore is above the industry median of Rs 696.43 crore across 199 companies.
About Sequent Scientific
Sequent Scientific Ltd. is a company in the Pharmaceuticals & Drugs industry, part of the Healthcare sector. Pharmaceutical businesses sit in the part of the healthcare sector that develops and sells medicines.
This note therefore sticks to the sector and industry classification and the reported ratios. For Sequent Scientific company news and later financial results, readers can follow the stock page on Univest.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Sequent Scientific share price rising today?
Ans. Univest data confirms the move itself, though no company-specific trigger has been identified. The stock traded at Rs 227.40, up 5.74% from the previous close of Rs 215.05, with market capitalisation at Rs 9,166.59 crore.
What is the Sequent Scientific share price today?
Ans. Sequent Scientific share price was last at Rs 227.40 as of 28 October 2026 at 12:07:37 PM IST. That is a gain of Rs 12.35, or 5.74%, over the previous close of Rs 215.05.
What is the market capitalisation of Sequent Scientific?
Ans. Sequent Scientific market cap stands at Rs 9,166.59 crore at the current price of Rs 227.40. The industry median across 199 companies is Rs 696.43 crore, so the company sits well above that median.
What is the P/E ratio of Sequent Scientific?
Ans. The P/E ratio of Sequent Scientific is 55.50. The industry median is 30.74 and the average is 43.30, so the multiple sits above both. The range across 170 companies with a P/E runs from 3.21 to 577.05.
What are the ROE and ROCE of Sequent Scientific?
Ans. Sequent Scientific reports ROE of 9.06% and ROCE of 13.10%. The industry median ROE is 11.23% and median ROCE is 13.17%, so ROE sits below its benchmark median and ROCE sits just below its median for the same industry.
What are the EPS and book value of Sequent Scientific?
Ans. EPS is Rs 3.87 and book value per share is Rs 63.66. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share. The stock trades at a P/B ratio of 3.38.
Does Sequent Scientific pay a dividend?
Ans. According to latest Univest data, the dividend yield of Sequent Scientific is 0.00%. Dividend yield is historical data relating the payout to the current price, and it is not a guarantee of any future payout by the company.
How does Sequent Scientific compare with its peers?
Ans. Sequent Scientific has a P/E of 55.50 against peers between 25.79 and 105.74, and ROE of 9.06% against peers between 14.85% and 26.76%. Its market cap of Rs 9,166.59 crore is below each of the five peers shown.
Track Sequent Scientific Share Price on Univest
Use Sequent Scientific Ltd. (VIYASH) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Univest lets users track the live Sequent Scientific Share Price, fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and wider market insights in one place. The stock page carries the latest price, day range and valuation metrics, and the Univest peer pages make it simple to compare Sequent Scientific with other Pharmaceuticals & Drugs names. All of this is information, not advice.
